Relative association of bowel urgency clinically meaningful improvement and bowel urgency remission versus stool frequency remission and rectal bleeding remission with improvement in Work Productivity and Activity Impairment Scores in patients with moderately-to-severely active Ulcerative Colitis: An analysis from LUCENT-1 and LUCENT-2 Phase 3 clinical trials.

被引：0
|
作者：
Sands, B. E. [1 ]
Feagan, B. G. [2 ,3 ]
Gibble, T. H. [4 ]
Keohane, A. [4 ]
Eastman, W. J. [4 ]
Traxler, K. A. [4 ]
Schreiber, S. [5 ]
Jairath, V. [2 ]
Armuzzi, A. [6 ]
机构：
[1] Icahn Sch Med, Gastroenterol, New York, NY USA
[2] Western Univ, Epidemiol & Biostat, London, ON, Canada
[3] Alimentiv Inc, Epidemiol & Biostat, London, ON, Canada
[4] Eli Lilly & Co, Immunol, Indianapolis, IN 46285 USA
[5] Univ Kiel, Dept Internal Med, Univ Hosp Schleswig Holstein, Kiel, Germany
[6] Humanitas Res Hosp, Gastroenterol, Milan, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P646
引用
收藏
页码：775 / 776
页数：2
相关论文
共 12 条
  • [1] Relative association of bowel urgency clinically meaningful improvement or bowel urgency remission versus stool frequency remission and rectal bleeding remission with improvement in Inflammatory Bowel Disease Questionnaire scores in patients with moderately-to-severely active Ulcerative Colitis: An analysis from LUCENT-1 and LUCENT-2 phase 3 clinical trials
    Sands, B. E.
    Feagan, B.
    Gibble, T. H.
    Keohane, A.
    Eastman, W.
    Traxler, K.
    Schreiber, S.
    Jairath, V.
    Armuzzi, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 523 - 524
  • [2] RELATIVE ASSOCIATION OF BOWEL URGENCY CLINICALLY MEANINGFUL IMPROVEMENT OR BOWEL URGENCY REMISSION VS STOOL FREQUENCY REMISSION AND RECTAL BLEEDING REMISSION WITH IMPROVEMENT IN IBDQ SCORES: RESULTS FROM LUCENT-1 AND LUCENT-2
    Sands, Bruce E.
    Feagan, Brian G.
    Gibble, Theresa H.
    Keohane, Anthony
    Eastman, William J.
    Traxler, Kristina A.
    Schreiber, Stefan
    Jairath, Vipul
    Armuzzi, Alessandro
    GASTROENTEROLOGY, 2023, 164 (06) : S686 - S687
  • [3] Relative association of bowel urgency improvement versus remission of stool frequency and rectal bleeding with Patient Global Rating of Severity or Change scores in moderately-to-severely active Ulcerative Colitis: An analysis from the LUCENT-1 and LUCENT-2 Phase 3 trials
    Travis, S.
    Wu, J.
    Keohane, A.
    Gibble, T. H.
    Hibi, T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 873 - 873
  • [4] BOWEL URGENCY OUTCOMES ARE ASSOCIATED WITH IMPROVEMENT IN FATIGUE IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: A POOLED ANALYSIS OF LUCENT-1 AND LUCENT-2 PHASE 3 TRIALS
    Rubin, David T.
    Hindryckx, Pieter
    Hibi, Toshifumi
    McGinnis, Kim
    Gibble, Theresa H.
    Keohane, Anthony
    Regueiro, Miguel D.
    GASTROENTEROLOGY, 2023, 164 (06) : S213 - S213
  • [5] IMPROVEMENT IN BOWEL URGENCY IS ASSOCIATED WITH STOOL FREQUENCY AND RECTAL BLEEDING REMISSION AT 12 AND 52 WEEKS IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS
    Long, Millie
    Gisbert, Javier
    McGinnis, Kim
    Ferrante, Marc
    Rogler, Gerhard
    Sapin, Christophe
    Hunter, Theresa
    Milata, Joe
    Navabi, Seyedehsan
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S10 - S11
  • [6] Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies
    Long, Millie D.
    Schreiber, Stefan
    Hibi, Toshifumi
    Gibble, Theresa Hunter
    Fisher, Deborah A.
    Park, Gina
    Moses, Richard E.
    Higgins, Peter D. R.
    Lindsay, James O.
    Lee, Scott D.
    Escobar, Rodrigo
    Jairath, Vipul
    CROHNS & COLITIS 360, 2024, 6 (01)
  • [7] IMPROVEMENT IN BOWEL URGENCY IS ASSOCIATED WITH STOOL FREQUENCY AND RECTAL BLEEDING REMISSION AT 12 AND 52 WEEKS IN PATIENTS WITH MODERATELY-TOSEVERELY ACTIVE ULCERATIVE COLITIS
    Long, Millie
    Gisbert, Javier
    McGinnis, Kim
    Ferrante, Marc
    Rogler, Gerhard
    Sapin, Christophe
    Hunter, Theresa
    Milata, Joe
    Navabi, Seyedehsan
    GASTROENTEROLOGY, 2023, 164 (04) : S13 - S14
  • [8] Mirikizumab Demonstrates Sustained Improvement in Fatigue in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies
    Regueiro, Miguel
    Gibble, Theresa Hunter
    Bleakman, Alison Potts
    Li, Xingyuan
    Morris, Nathan
    Eastman, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S518 - S519
  • [9] Mirikizumab Improves Work Productivity and Activity Impairment Questionnaire Scores in Moderately-to-Severely Active UC: The LUCENT-1 and LUCENT-2 Randomized, Double-Blind, PlaceboControlled Phase 3 Studies
    Sands, Bruce E.
    Feagan, Brian
    Gibble, Theresa Hunter
    Traxler, Kristina A.
    Morris, Nathan
    Li, Xingyuan
    Schreiber, Stefan
    Jairath, Vipul
    Armuzzi, Alessandro
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S529 - S530
  • [10] The Addition of Bowel Urgency Improvement to the Achievement of Clinical Response or Remission Was Associated with Better Work Productivity in Patients with Ulcerative Colitis from Mirikizumab Phase 3 Trials
    Rubin, David T.
    Wu, Jianmin
    Park, Bomina
    Baygani, Simin
    Morris, Nathan
    Gibble, Theresa Hunter
    Schreiber, Stefan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S682 - S683
12